Japan Tissue Engineering Hits Day Low of JPY 643 Amid Price Pressure

Japan Tissue Engineering Co., Ltd. has experienced significant volatility today, with the stock hitting an intraday low of JPY 643.00, reflecting a decline of 11.07%. This performance stands in contrast to the broader market, as the Japan Nikkei 225 index fell by 5.2% during the same period. Over the past week, Japan Tissue Engineering has seen a more pronounced drop of 16.28%, while its monthly performance shows a gain of 14.82%. However, the company's long-term growth metrics raise concerns, with net sales increasing at an annual rate of just 1.23% and operating profit at 4.14% over the last five years. The company reported a pre-tax profit of JPY -183.82 million, marking a decline of 85.11%, and a net profit of JPY -184.85 million, down 84.23%. With a market capitalization of JPY 21,726 million, Japan Tissue Engineering operates within the pharmaceuticals and biotechnology sector. The company currently shows a return on equity of -7.36% and a negative EBITDA, indicating challenges in profitability and operational efficiency.